Table 3. Treatment-related adverse events.
Toxicity | Grade | No. of patients (all cycles) |
---|---|---|
Figitumumab related | ||
Elevated ALT | 1/2 | 5 |
3/4 | 0 | |
Elevated GGT | 1/2 | 3 |
3/4 | 0 | |
Fatigue | 1/2 | 2 |
3/4 | 1 | |
Hyperglycaemia | 1/2 | 1 |
3/4 | 1 | |
Muscle spasm | 1/2 | 3 |
3/4 | 0 | |
Nausea | 1/2 | 3 |
3/4 | 0 | |
Docetaxel related | ||
Alopaecia | 1/2 | 3 |
3/4 | 0 | |
Anorexia | 1/2 | 6 |
3/4 | 0 | |
Cellulitis | 1/2 | 0 |
3/4 | 1 | |
Diarrhoea | 1/2 | 8 |
3/4 | 5 | |
Deep-vein thrombosis | 1/2 | 1 |
3/4 | 1 | |
Fatigue | 1/2 | 16 |
3/4 | 9 | |
Febrile neutropaeniaa | 1/2 | 0 |
3/4 | 11 | |
Leukopaenia | 1/2 | 3 |
3/4 | 7 | |
Lymphopaenia | 1/2 | 2 |
3/4 | 1 | |
Mucositis | 1/2 | 4 |
3/4 | 0 | |
Nausea | 1/2 | 3 |
3/4 | 0 | |
Neutropaenia | 1/2 | 4 |
3/4 | 28 | |
Pain | 1/2 | 3 |
3/4 | 1 |
Abbreviations: ALT=alanine aminotransferase; GGT=γ-glutamyl transferase.
Includes neutropenic sepsis.